Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA; Health Protection and Promotion Operational Unit, Northrop Grumman, Atlanta, GA.
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
Am J Infect Control. 2018 Jun;46(6):649-655. doi: 10.1016/j.ajic.2017.11.018. Epub 2018 Jan 9.
Outbreaks of health care-associated infections (HAIs) caused by Burkholderia cepacia complex (Bcc) have been associated with medical devices and water-based products. Water is the most common raw ingredient in nonsterile liquid drugs, and the significance of organisms recovered from microbiologic testing during manufacturing is assessed using a risk-based approach. This incident demonstrates that lapses in manufacturing practices and quality control of nonsterile liquid drugs can have serious unintended consequences.
An epidemiologic and laboratory investigation of clusters of Bcc HAIs that occurred among critically ill, hospitalized, adult and pediatric patients was performed between January 1, 2016, and October 31, 2016.
One hundred and eight case patients with Bcc infections at a variety of body sites were identified in 12 states. Two distinct strains of Bcc were obtained from patient clinical cultures. These strains were found to be indistinguishable or closely related to 2 strains of Bcc obtained from cultures of water used in the production of liquid docusate, and product that had been released to the market by manufacturer X.
This investigation highlights the ability of bacteria present in nonsterile, liquid drugs to cause infections or colonization among susceptible patients. Prompt reporting and thorough investigation of potentially related infections may assist public health officials in identifying and removing contaminated products from the market when lapses in manufacturing occur.
洋葱伯克霍尔德菌复合群(Bcc)引起的医源性感染(HAIs)暴发与医疗器械和水基产品有关。水是非无菌液体药物最常见的原料,在制造过程中微生物检测中回收的微生物使用基于风险的方法进行评估。这一事件表明,非无菌液体药物制造实践和质量控制的失误可能会产生严重的意外后果。
对 2016 年 1 月 1 日至 10 月 31 日期间发生在危重病、住院、成年和儿科患者中的洋葱伯克霍尔德菌 HAIs 聚集事件进行了流行病学和实验室调查。
在 12 个州发现了 108 例不同部位感染洋葱伯克霍尔德菌的病例患者。从患者临床培养物中获得了两种不同的洋葱伯克霍尔德菌菌株。这些菌株与从用于生产液体多库酯的水中培养的 2 株洋葱伯克霍尔德菌以及制造商 X 生产的已投放市场的产品中获得的 2 株洋葱伯克霍尔德菌菌株无法区分或密切相关。
本调查强调了存在于非无菌液体药物中的细菌引起易感患者感染或定植的能力。及时报告和彻底调查潜在相关感染,可能有助于公共卫生官员在制造失误导致产品污染时识别和从市场上移除污染产品。